|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.620 USD | -0.12% |
|
-14.23% | +19.56% |
| 06-09 | Cartesian Therapeutics Signs Licensing Agreement With WestGene to Develop Therapies for Autoimmune Diseases | MT |
| 05-26 | Cartesian Therapeutics, Inc. Announces Executive Changes | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.12% | -14.23% | +0.23% | +35.75% | +19.56% | -34.00% | - | - | - | 254M | |
| +6.05% | +3.69% | +27.88% | +20.62% | +40.68% | +65.28% | +89.94% | -19.20% | - | 53.54B | |
| +0.21% | -6.37% | -2.86% | +12.44% | +6.19% | +58.42% | +128.79% | +191.76% | +5,546.88% | 54.18B | |
| +0.89% | -2.42% | +12.98% | -28.22% | -36.73% | +8.07% | +434.51% | +302.01% | +892.88% | 23.66B | |
| +0.37% | -4.13% | -0.44% | -8.14% | -5.04% | -18.56% | -16.48% | -57.36% | - | 22.78B | |
| +2.36% | +1.06% | +22.91% | +8.28% | +21.50% | +43.34% | -6.14% | -70.91% | - | 19.54B | |
| -2.29% | +1.78% | +14.89% | +3.59% | -8.24% | +34.98% | -28.10% | -32.29% | +57.23% | 17.82B | |
| -4.00% | -7.88% | +40.27% | +105.74% | +183.22% | +175.60% | +343.60% | +1,550.50% | +643.02% | 16.01B | |
| -1.15% | -4.83% | +19.99% | +2.26% | +27.03% | +46.53% | +627.30% | - | - | 15.37B | |
| -0.48% | -2.30% | +5.23% | +21.61% | +27.24% | +22.36% | +187.62% | +218.87% | +578.47% | 14.09B | |
| +1.10% | -1.56% | +7.42% | +2.26% | -7.81% | +67.84% | +137.79% | +458.71% | - | 12.24B | |
| +1.11% | -2.58% | +9.48% | -25.80% | -11.55% | -39.09% | +622.90% | +116.97% | +114.56% | 11.88B | |
| -0.38% | -4.24% | +14.78% | +23.48% | +28.94% | +112.36% | +134.55% | +341.91% | +744.64% | 11.17B | |
| +0.63% | -5.94% | +4.18% | -30.44% | -15.18% | -15.33% | +153.91% | +57.78% | - | 11.19B | |
| -2.97% | -17.32% | -6.79% | +7.83% | +8.31% | +286.41% | +107.83% | +14.98% | +1,198.01% | 10.44B | |
| +0.02% | +0.15% | +0.49% | +18.03% | +23.23% | +46.54% | +199.13% | - | - | 9.83B | |
| +0.92% | -6.09% | +10.66% | -24.93% | +14.58% | +30.54% | +86.65% | -21.28% | - | 9.08B | |
| +0.05% | +0.22% | +138.35% | +110.59% | +79.83% | +153.51% | +310.95% | +324.28% | - | 8.82B | |
| +1.16% | -10.05% | +10.52% | +3.68% | +297.98% | +171.72% | +183.45% | -29.71% | - | 8.16B | |
| +5.57% | +5.01% | +18.39% | +54.59% | +202.05% | +502.99% | +608.05% | -43.54% | -14.88% | 8.24B | |
| Average | +0.45% | +1.36% | +17.43% | +15.66% | +44.79% | +85.97% | +226.65% | +194.32% | +1,084.53% | 16.91B | |
| Weighted average by Cap. | +1.02% | +0.99% | +15.60% | +12.78% | +31.66% | +70.37% | +190.20% | +175.31% | +2,168.48% |
- Stock Market
- Stocks
- RNAC Stock
- Sector Cartesian Therapeutics, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
